eric dannaoui
eric dannaoui
Université de Paris - Hôpital Européen G. Pompidou
Verified email at
Cited by
Cited by
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group …
OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ...
The Lancet infectious diseases 19 (12), e405-e421, 2019
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013
OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ...
Clinical Microbiology and Infection 20, 5-26, 2014
A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007)
F Lanternier, E Dannaoui, G Morizot, C Elie, D Garcia-Hermoso, M Huerre, ...
Clinical Infectious Diseases 54 (suppl_1), S35-S43, 2012
Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006
D Bitar, D Van Cauteren, F Lanternier, E Dannaoui, D Che, F Dromer, ...
Emerging infectious diseases 15 (9), 1395, 2009
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility …
JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical Microbiology and Infection 14 (4), 398-405, 2008
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ...
Clinical Microbiology and Infection 20, 27-46, 2014
Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go …
SA Balajee, AM Borman, ME Brandt, J Cano, M Cuenca-Estrella, ...
Journal of clinical microbiology 47 (4), 877-884, 2009
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus
JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ...
Emerging infectious diseases 21 (6), 1041, 2015
Invasive fungal diseases during COVID-19: we should be prepared
JP Gangneux, ME Bougnoux, E Dannaoui, M Cornet, JR Zahar
Journal de mycologie medicale 30 (2), 100971, 2020
In vitro susceptibilities of zygomycetes to conventional and new antifungals
E Dannaoui, J Meletiadis, JW Mouton, JFGM Meis, PE Verweij
Journal of Antimicrobial Chemotherapy 51 (1), 45-52, 2003
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi
A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ...
Clinical Microbiology and Infection 20, 47-75, 2014
Healthcare-associated mucormycosis
B Rammaert, F Lanternier, JR Zahar, E Dannaoui, ME Bougnoux, ...
Clinical Infectious Diseases 54 (suppl_1), S44-S54, 2012
Molecular identification of zygomycetes from culture and experimentally infected tissues
P Schwarz, S Bretagne, JC Gantier, D Garcia-Hermoso, O Lortholary, ...
Journal of Clinical Microbiology 44 (2), 340-349, 2006
Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, MC Arendrup, MA Pfaller, LX Bonfietti, B Bustamante, ...
Antimicrobial agents and chemotherapy 57 (12), 5836-5842, 2013
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
JP Gangneux, E Dannaoui, A Fekkar, CE Luyt, F Botterel, N De Prost, ...
The Lancet Respiratory Medicine 10 (2), 180-190, 2022
Activity of posaconazole in treatment of experimental disseminated zygomycosis
E Dannaoui, JFGM Meis, D Loebenberg, PE Verweij
Antimicrobial agents and chemotherapy 47 (11), 3647-3650, 2003
Acquired resistance to echinocandins in Candida albicans: case report and review
MT Baixench, N Aoun, M Desnos-Ollivier, D Garcia-Hermoso, S Bretagne, ...
Journal of antimicrobial chemotherapy 59 (6), 1076-1083, 2007
Acquired itraconazole resistance in Aspergillus fumigatus
E Dannaoui, E Borel, MF Monier, MA Piens, S Picot, F Persat
Journal of Antimicrobial Chemotherapy 47 (3), 333-340, 2001
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
F Lanternier, S Poiree, C Elie, D Garcia-Hermoso, P Bakouboula, ...
Journal of Antimicrobial Chemotherapy 70 (11), 3116-3123, 2015
Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales
RG Vitale, GS De Hoog, P Schwarz, E Dannaoui, S Deng, M Machouart, ...
Journal of clinical microbiology 50 (1), 66-75, 2012
The system can't perform the operation now. Try again later.
Articles 1–20